Literature DB >> 12752521

Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.

Timothy Corcoran Flynn1, Robert E Clark.   

Abstract

BACKGROUND: Botulinum toxin types A and B can improve the appearance of facial wrinkles. Differences in the time until onset and the degree of diffusion have been observed anecdotally, but no direct comparative studies have been done.
OBJECTIVE: To compare the rate of onset and the radius of diffusion of botulinum toxin types A and B in the rhytides of the forehead.
METHODS: Adults with symmetrical moderate to severe forehead wrinkles at full contracture received botulinum toxin type A (BOTOX; 5 U) on one side of the forehead and type B (MYOBLOC; 500 U) on the other side. Photographs taken at rest and full frontalis contracture were analyzed by computer, and a time-lapse motion picture was created. Radius of diffusion and time until full effect were measured.
RESULTS: Botulinum toxin type B had a slightly faster onset of action than type A. All patients responded to type B quickly, whereas some had a delayed response to type A. A greater radius of diffusion was consistently observed with botulinum toxin type B, as measured by the greater area of wrinkle reduction at the doses used.
CONCLUSIONS: In this comparative study of patients with symmetrical forehead wrinkles, botulinum toxin type B produced a greater area of diffusion and a more rapid onset of action than type A.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752521     DOI: 10.1046/j.1524-4725.2003.29124.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

Review 1.  Pharmacological Management of Chronic Pelvic Pain in Women.

Authors:  Erin T Carey; Sara R Till; Sawsan As-Sanie
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].

Authors:  K-U Kern; M Kohl; U Seifert; T Schlereth
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

3.  Botulinum Toxin A for the Treatment of Sympathomimetic Pressor-Induced Digital Hand Ischemia in the Critically Ill Intensive Care Unit Patient.

Authors:  Henning De May; Avra S Laarakker; Gregory Borah
Journal:  Hand (N Y)       Date:  2022-02-21

4.  A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis.

Authors:  Dong Geon Lee; Jung Eun Kim; Woo Shun Lee; Moon-Bum Kim; Chang-Hun Huh; Yang Won Lee; Gwang Seong Choi; Jee-Bum Lee; Dong Soo Yu; Min Kyung Shin; Mi Ryung Roh; Hyo Hyun Ahn; Won-Serk Kim; Jong Hee Lee; Kui Young Park; Jin Park; Weon Ju Lee; Mi Youn Park; Hoon Kang
Journal:  Aesthetic Plast Surg       Date:  2022-02-07       Impact factor: 2.708

Review 5.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

6.  Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.

Authors:  Maciej Gasior; Rebecca Tang; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2013-06-14       Impact factor: 4.030

7.  Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines.

Authors:  Gabriele Stengel; Eva Kristina Bee
Journal:  Clin Interv Aging       Date:  2011-11-09       Impact factor: 4.458

8.  Diffusion of botulinum toxins.

Authors:  Matthew A Brodsky; David M Swope; David Grimes
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.